Healthcare Supplies company Poly Medicure announced Q1FY26 results Total Income: Rs 444.9 crore compared to Rs 401.7 crore during Q1FY25, change 10.7%. EBITDA: Rs 106.1 crore compared to Rs 103.8 crore during Q1FY25, change 2.1%. EBITDA Margin: 26.3% for Q1FY26. PAT: Rs 93.1 crore compared to Rs 74.0 crore during Q1FY25, change 25.5%. PAT Margin: 20.9% for Q1FY26 Himanshu Baid, Managing Director, Poly Medicure, said: "We are pleased to share that we started the year on a steady note, with our Domestic revenue continuing to demonstrate strong growth momentum. This is supported by a healthy operating margin, enhanced PAT performance and significant product innovations all while continuing to invest in sustainability, scale, and future capacity through R&D; and green initiatives. Our renal division continues to grow at a robust pace, and with the commercialization of our Critical Care and Cardiology division last year, we are further expanding our presence in the larger Medical Devices industry. While short term challenges persist due to geopolitical tensions and recent tariff changes, we remain confident about the long term opportunity in for the Indian Medical Devices sector and continue to position ourselves strongly to capture that. We remain steadfast to our vision of “Serving people through innovative healthcare solutions”. Result PDF